Polycystin-1 regulates STAT activity by a dual mechanism
- 25 April 2011
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 108 (19), 7985-7990
- https://doi.org/10.1073/pnas.1103816108
Abstract
Mutations in polycystin-1 (PC1) lead to autosomal-dominant polycystic kidney disease (ADPKD), a leading cause of renal failure for which no treatment is available. PC1 is an integral membrane protein, which has been implicated in the regulation of multiple signaling pathways including the JAK/STAT pathway. Here we show that membrane-anchored PC1 activates STAT3 in a JAK2-dependent manner, leading to tyrosine phosphorylation and transcriptional activity. The C-terminal cytoplasmic tail of PC1 can undergo proteolytic cleavage and nuclear translocation. Tail-cleavage abolishes the ability of PC1 to directly activate STAT3 but the cleaved PC1 tail now coactivates STAT3 in a mechanism requiring STAT phosphorylation by cytokines or growth factors. This leads to an exaggerated cytokine response. Hence, PC1 can regulate STAT activity by a dual mechanism. In ADPKD kidneys PC1 tail fragments are overexpressed, including a unique ∼15-kDa fragment (P15). STAT3 is strongly activated in cyst-lining epithelial cells in human ADPKD, and orthologous and nonorthologous polycystic mouse models. STAT3 is also activated in developing, postnatal kidneys but inactivated in adult kidneys. These results indicate that STAT3 signaling is regulated by PC1 and is a driving factor for renal epithelial proliferation during normal renal development and during cyst growth.Keywords
This publication has 32 references indexed in Scilit:
- Molecular Advances in Autosomal Dominant Polycystic Kidney DiseaseAdvances in Chronic Kidney Disease, 2010
- Rapamycin Ameliorates PKD Resulting from Conditional Inactivation of Pkd1Journal of the American Society of Nephrology, 2010
- Advances in the pathogenesis and treatment of polycystic kidney diseaseCurrent Opinion in Nephrology and Hypertension, 2009
- Polycystic Kidney DiseaseAnnual Review of Medicine, 2009
- Targeting STAT3 in cancer: how successful are we?Expert Opinion on Investigational Drugs, 2008
- IL-6/IL-6R Axis Plays a Critical Role in Acute Kidney InjuryJournal of the American Society of Nephrology, 2008
- A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1Nature Medicine, 2007
- The isolated polycystin-1 COOH-terminal can activate or block polycystin-1 signalingBiochemical and Biophysical Research Communications, 2007
- The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 2004
- Delayed cystogenesis and increased ciliogenesis associated with the re-expression of polaris in Tg737 mutant miceKidney International, 2003